PRINCETON, N.J., June 11, 2024 (GLOBE NEWSWIRE) — Origin Life Sciences, Inc., a clinical-stage biotechnology company developing a proprietary patented […]
Focus on Higher Return Projects Results in Approximately $300 Million Capital Expenditure Reduction and $60 Million Expense Savings Fiber Strategic Review […]